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doi:10.1016/j.ejvs.2010.10.003Abstract Objectives: To assess the accuracy of colour-Doppler ultrasound (CDUS), contrast-
enhanced ultrasonography (CEUS), computed tomography angiography (CTA) and magnetic
resonance angiography (MRA) in detecting endoleaks after endovascular abdominal aortic
aneurysm repair (EVAR).
Design: Prospective, observational study.
Materials and methods: From December 2007 to April 2009, 108 consecutive patients who
underwent EVAR were evaluated with CDUS, CEUS, CTA and MRA as well as angiography, if
further treatment was necessary. Sensitivity, specificity, accuracy and negative predictive
value of ultrasound examinations were compared with CTA and MRA as the reference stan-
dards, or with angiography when available.
Results: Twenty-four endoleaks (22%, type II: 22 cases, type III: two cases) were documented.
Sensitivity and specificity of CDUS, CEUS, CTA, and MRA were 58% and 93%, 96% and 100%, 83%
and 100% and 96% and 100% respectively. CEUS allowed better classification of endoleaks in 10,
two and one patients compared with CDUS, CTA and MRA, respectively.education questions on this paper, please go to www.vasculareducation.com and click on ‘CME’.
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US, CEUS, CTA and MRA after EVAR 187Conclusions: The accuracy of CEUS in detecting endoleaks after EVAR is markedly better than
CDUS and is similar to CTA and MRA. CEUS seems to be a feasible tool in the long-term surveil-
lance after EVAR, and it may better classify endoleaks missed by other imaging techniques.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Endovascular abdominal aortic aneurysm repair (EVAR) is an
effective alternative treatment to open repair,1 and the
number of EVAR procedures carried out worldwide is
continuously growing. Incomplete exclusion of the aneu-
rysm sac from the circulation, defined as endoleak, is the
most frequent complication after EVAR occurring in 10e45%
of cases,2 and it can be associated with aneurysm
enlargement and rupture.3 Thus, lifelong surveillance of
aortic stent grafts to detect endoleaks and other forms of
device failure is required in patients who undergo EVAR.
Standard Duplex ultrasound investigation was first adopted
in the follow-up of conventional vascular procedures for
reasons of low cost, easy interpretation and performance
and no radiation exposure, but it has not achieved refer-
ence standard status in the EVAR follow-up because of low
diagnostic specificity and sensitivity.4,5 To date, computed
tomography angiography (CTA) is the preferred imaging
modality to follow-up patients after EVAR. However, it
carries the risks associated with radiation and contrast-
media exposure. Magnetic resonance angiography (MRA)
and contrast-enhanced ultrasonography (CEUS) have been
shown to be more accurate than CTA,6e13 but, so far, there
is no consensus regarding the optimal diagnostic imaging
modalities for surveillance after EVAR. The accuracy of
these imaging modalities in the detection and character-
isation of endoleaks in aortic stent grafts has been inves-
tigated in this prospective study.Materials and Methods
Study population
From December 2007 to April 2009, 123 consecutive
patients (92 males and 31 females, mean age 63.0  7.3
years), who have undergone EVAR for abdominal aortic
aneurysm (aneurysm baseline mean diameter 5.4  0.5 cm,
range: 3.9e8.7 cm), were prospectively recruited in the
present study. The EVAR devices employed in these patients
were the Excluder (W.L. Gore & Associates, Flagstaff, AZ,
USA) in 50 patients, the Talent (Medtronic, Santa Rosa, CA,
USA) in 55, the Powerlink (Endologix, Irvine, CA, USA) in 12
and the Jomed (Jomed International AB, Helsingborg,
Sweden) in six patients.
Patients underwent regular follow-up at our institution
at 1, 6 and 12 months and only some of them at 24 months,
with imaging procedures including colour-Doppler ultra-
sound (CDUS) and CEUS on the same day, and, within 1
week, CTA and MRA.
The radiologists were blinded to the results of any
previous examination. DSA was performed in case of
contradictory results at different modalities. Furthermore,
the cases positive for endoleak and considered for possible
re-intervention underwent also digital subtraction angiog-
raphy (DSA) study and were eventually treated.Ethical Committee approved this study and all patients
signed the informed consent. The authors did not receive
any outside funding for this study. There are no conflicting
interests inherent in this study.
CEUS protocol
Patients were suggested to have a low residual diet the day
before the ultrasound study and to fast in the morning of
the investigation. CDUS and CEUS examinations were per-
formed by two radiologists (P.R. and V.C. with 20 and 10
years of experience in this particular field, respectively)
with Aplio XV, (Toshiba Vx, Zoetermeer, the Netherlands)
and Technos MPX ultrasound (ESAOTE Biomedica, Genoa,
Italy) equipments, using a 3e5 MHz probe, with longitudinal
and transversal scans with the patient lying in a dorsal or
lateral position. In a single patient, one radiologist per-
formed CDUS and the other CEUS, but this assignment
(which examination by whom radiologist) was at random for
each case. The entire abdominal aorta was scanned from
the diaphragm to the iliac arteries and the entire sac was
analysed to detect possible pulsatility colour flow within
the aneurysm sac. The aneurysm sac size was measured in
both anterioreposterior and transverse dimensions at its
widest point and the mean of these measurements was
used for the purposes of this study. Arterial flow haemo-
dynamics were documented throughout the stent graft with
spectral Doppler velocity measurements. Colour-Doppler
was adjusted for optimum sensitivity to slow flows, and the
entire stent graft and aneurysm sac were scanned to detect
any endoleak that might have been present. Any suspected
endoleak was further documented for flow characteristics
with spectral Doppler velocities. Subsequently, patients
underwent CEUS with a 3e5-MHz probe and with a low
mechanical index (varying from 0.06 to 0.10; about
35e45 kPa), with real-time tissue harmonic imaging
(contrast-tuned imaging CnTI using Technos MPX, Esaote)
and contrast harmonic imaging (pulse subtraction) (Aplio,
Toshiba Corp, Tochigi, Japan). These imaging techniques
enable selected tuning of the signal from the contrast-
agent microbubble resonance, notably filtering tissue
echoes. A second-generation contrast agent (SonoVue,
Bracco, Milan, Italy) consisting of sulphur hexafluoride gas
microbubbles in a phospholipid membrane, which presents
a longer persistence in the bloodstream under insonation by
low acoustic power, was injected intravenously in all cases.
A single bolus of 2.4 ml of the contrast agent was injected
in all patients into an antecubital vein followed by 5 ml of
saline. Images obtained in all patients were recorded in
digital form for subsequent analysis. CEUS scanning was
performed for at least 5 min after injection and assessed
the presence of contrast enhancement within the aneurysm
sac, with monitoring of the time of appearance (synchro-
nous or delayed with respect to graft enhancement) and
persistence (wash-out) to inflow and outflow vessels.
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CTA was performed with 64-slice CT scanner (Somaton
Sensation Siemens Medical Solutions, Erlangen, Germany). A
triple-phase CT protocolwas carried out with an unenhanced,
an arterial (with bolus-tracking) and a delayed phase at 120 s
(with 130 ml of non-ionic contrast media: Iomeron, Bracco,
Milan, Italy, flow 4 ml s1). Other scan parameters were as
follow: acquisition thickness 1.2mm; reconstructionwith soft
kernel algorithm (B30), 1.5 and 3 mm with 1.5 of recon
increment;pre-contrast scanswith lowtubecurrent (120mA);
for other phases, 120 kVp and 200 mAs.
Magnetic resonance protocol
All MRA examinations were conducted on a high-perfor-
mance 1.5-T scanner (Magnetom Avanto, Siemens Medical
System, Erlangen, Germany) with gradient strength of
45 mT m2 and slew rate of 200 T m1s1 and with
a multichannel phased array coil. Scout images were
obtained by acquiring fast true fisp imaging with steady
precession (FISP) sequences in the caudocranial direction at
the abdomen’s level.
Sequential pre-contrast images were obtained in the
caudocranial direction, using axial three-dimensional (3D)
fast low-angle shot (FLASH) sequences with integrated
parallel acquisition technique (IPAT) optimised for high
spatial resolution and short acquisition time (TR (time of
repetition) 3.5 ms, TE (time of echo) 1.18 ms, FA (flip angle)
30, voxel size 1.3 mm  0.9 mm  0.9 mm, matrix
256  512, TA (time of acquisition) 16 s, IPAT factor 2),
acquired in breath-hold. The protocol was repeated in the
craniocaudal direction after a single biphasic administra-
tion of contrast medium through a dual-head injector:
0.2 mmol kg1 of gadolinium benzyloxyproprionic tetra-
acetic acid (Gd-BOPTA, Bracco, Milano, Italy) was admin-
istered as a single bolus with a biphasic injection protocol
(first phase at a rate of 1 ml s1 and second phase at
0.5 ml s1), with 25 ml saline solution bolus chaser at a rate
of 0.5 ml s1. The optimal delay between contrast injection
and sequence acquisition was calculated by using the bolus-
tracking technique, with the start of image acquisition
synchronised with the arrival of contrast material in the left
cardiac cavities. The pre-contrast images were automati-
cally subtracted from the post-contrast images to increase
the contrast between the vasculature and the background.
Another scan was performed in the abdominal area 120 s
after contrast administration. The CTA and MRA images
were analysed in an independent dedicated work station
(Aquarius, TeraRecon, San Matteo, CA, USA) using the
common post-processing techniques. The images were
reviewed in consensus by two radiologists (CC and AN, both
of them with 15 and 8 years of specific experience,
respectively). We have evaluated the aneurysm sac size,
the attachment and integrity of the prosthesis and the
presence and type of any endoleak.
DSA
DSAwas performedwith a fluoroscopymachine (Integris 5000,
Philips Medical System, the Netherlands). A percutaneousfemoral approach was carried out. After insertion of a 4Fr
introducer sheath (Radifocus,Terumo, Tokyo, Japan) a 4Fr
pig-tail catheter(Cordis Endovascular, Miami Lakes, FL, USA)
wasadvanced into theabdominal aorta justabove theoriginof
the renal arteries where a DSA was performed, after the
injection of 20ml of iodinated contrastmedia at a flow rate of
20 ml s1. The correct sealing of the endoprosthesis at the
level of the proximal neck was evaluated. Afterwards,
a selective catheterisation of the superior mesenteric artery
was done, using a Sim1 catheter (Cordis Endovascular, Miami
Lakes, FL, USA) to evaluate the collateral flow within the
Riolano arcade and the excluded inferiormesenteric artery. If
no endoleaks were detected, a selective injection was also
performed at the level of both internal iliac arteries to eval-
uate sac revascularisation through the ileolumbar arteries.
Treatment of the endoleak was performed according to its
typeand sitebyusing different embolic agents (coils and glue)
or cuffs.
Statistical analysis
Statistical analysis was performed using a Statistical
Package for Social Sciences (SPSS) statistical software (SPSS
v. 16.0.1, SPSS Inc., Chicago, IL, USA). The maximal
external transverse aneurysm sac diameter was measured
with all diagnostic techniques and data were expressed as
mean  standard deviation. Variables herein evaluated
were changes in the maximum diameter of the aneurysm
sac as well as presence and type of endoleak, if detected.
Sensitivity, specificity, accuracy and negative predictive
values were estimated for each of these diagnostic
methods. Spearman’s correlation test was used to estimate
the correlation between measurements by different
imaging methods. Wilcoxon’s test was employed to esti-
mate the extent of aneurysm sac shrinkage. A p < 0.05 was
considered statistically significant.
Results
Of the initially recruited 123 patients, 15 patients were
excluded from this study because of the following reasons:
eight patients could not undergo MRA (claustrophobia, no.
2; pace-maker, no. 6), three patients because of renal
failure, one patient because of the allergy to iodine and
three because of presence of severe co-morbidity (heart
failure and severe pulmonary disease). Thus, the present
study includes 108 patients.
At the time of stent-graft evaluation, the mean follow-
up after EVAR was 13 months (range, 1e24 months). All
patients completed the protocol, and no adverse events
were recorded during CEUS, CTA and MRA examinations.
Among these patients, 24 endoleaks have been detected.
The mean diameters of the abdominal aortic aneurysm
sac at follow-up were 5.2  1.2, 5.1  1.1 and 5.2  1.1 cm
for CDUS/CEUS, CTA and MRA, respectively. Aneurysm sac
size at baseline and at control as measured by ultrasound
significantly correlated with CTA measurements (rho 0.903
and rho 0.813, respectively) and MRA measurements (rho
0.870 and rho 0.781, respectively). During follow-up, the
aneurysm sac shrank by 0.3  0.4 cm (range, 1.4e0.8 cm,
Wilcoxon’s test: p < 0.0001). The aneurysm sac shrank in 77
US, CEUS, CTA and MRA after EVAR 189(71.3%) patients, did not change in size in 24 (22.2%)
patients and increased in size in seven (6.5%) patients.
Change in the aneurysm sac size was 0.4  0.3 cm (range
1.4e0.0 cm) among those patients without any endoleak
(84 patients), whereas it was 0.0  0.5 cm (range
1.2e0.8 cm, ManneWhitney’s test: p Z 0.002) in those
with endoleak (24 patients). In all patients without endo-
leak at the standard of reference, the aneurysm sac always
decreased or remained unchanged, without any complica-
tion. Therefore, no diagnosis of endotension was made.
Twenty two of the detected endoleaks were of type II,
18 due to retrograde flow into the aneurysm sac through the
lumbar arteries and four from the inferior mesenteric
artery. Two type III endoleaks were detected as well.
All examinations visualised graft patency and graft
integrity in all patients. Three out of four patients in whom
CTA was not able to identify any endoleak were treated
because the diagnosis of endoleak based on CEUS and MRA
findings was confirmed by angiography, and it was associ-
ated with growth of the aneurysm sac. More in detail, CDUS
examinations suggested 20 endoleaks, seven of which were
false positives, whilst endoleak was not detected in 10
cases, due to the patient’s physical constitution and stent’s
metallic artefacts.
CTA detected endoleak in 20 patients and did not iden-
tify four small type II endoleaks (Fig. 1). Sixteen type IIFigure 1 Figures summarizing the findings according to four diffe
repair of an abdominal aortic aneurysm: A) Colour-Doppler ultrasou
indicates a hypertrophic lumbar artery); B) computed tomograp
aneurysm sac (arrow indicates the place where the endoleak is no
and D) contrast-enhanced ultrasound: focal contrast-enhancement
endoleak.endoleaks detected at CTA examination were low-flow
endoleaks as identified at the delayed phase.
All but one of the endoleaks was correctly identified by
the CEUS and MRA examinations; no false positive occurred
with these imaging methods. CEUS better classified two
endoleaks identified at CTA and one at MRA. At CTA, the
two incorrectly classified endoleaks were one type II
instead of type III endoleak, and one type III instead of type
II endoleak. The case detected at MRA as type III endoleak
was shown to be a type II endoleak at CEUS as confirmed by
angiography. The accuracy of these diagnostic methods in
detecting endoleaks is summarised in Table 1.
According to these results, CEUS was markedly more
accurate than CDUS in the identification of leaks and its
accuracy was also slightly better than CTA and similar to
MRA. It is worth noting that CEUS allowed better classifi-
cation of endoleaks in 10, two and one cases compared with
CDUS, CTA and MRA, respectively. The four cases of missed
endoleak at CTA could be explained by the metallic arte-
fact resulting in suboptimal imaging, and because the
endoleaks were too small.
Overall, DSA and treatment of the endoleak were per-
formed in 10 patients. Two patients with type III endoleak
were successfully treated by covering the defect with
a stent-graft extension. Six patients with important type II
endoleaks with progressive increase of the aneurysmal sacrent imaging methods of a type II endoleak after endovascular
nd: no flow signal is detected within the aneurysm sac (arrow
hy angiography: no focal contrast-enhancement within the
t evident due to artefacts; C) magnetic resonance angiography
behind the iliac branches during arterial phase consistent with











Sensitivity Specificity Accuracy Negative
predictive
value
CDUS 14 6 10 78 58% 93% 85% 89%
CEUS 23 0 1 84 96% 100% 99% 99%
CTA 20 0 4 84 83% 100% 96% 95%
MRA 23 0 1 84 96% 100% 99% 99%
CDUS: Colour-Doppler ultrasound; CEUS: contrast-enhanced ultrasound; CTA: computed tomography angiography; MRA: magnetic
resonance angiography.
190 V. Cantisani et al.were treated with coil embolisation. The two remaining
patients were not treated as the degree of endoleak was
very small and a watchful, waiting strategy was indicated.Discussion
EVAR is widely used as it is less invasive than open
repair.1,14e17 Surveillance of patients after EVAR is crucial for
evaluating its technical success and possible complications
such as endoleaks.17 When indicated, endoleaks should be
treated to avoid the risk of aneurysm rupture.18,19
Endoleak has been reported in as many as 44% of EVAR
cases,20 type II endoleak having been reported in 6e30% of
patients.3,21 Most of type II endoleaks resolve spontane-
ously within 6 months since detection,22 whereas type I and
type III, although being uncommon, are significantly related
to a high risk of aneurysm rupture, and should be treated as
soon as detected.3,21
This prospective multimodality evaluation for EVAR was
performed to settle the controversy on the optimal follow-
up method of EVAR patients.7,23 The imaging method of
choice should be cheap, repeatable, safe, non-invasive and
accurate. CDUS is safe, cheap, and repeatable, but in our
and other authors’ experience,4,5,9 it performed poorly in
detecting endoleaks. This is mainly due to the burden of
artefacts detected at CDUS.
CTA is the most used modality as it is widely available,
with rapid acquisition and high diagnostic value.23,24
However, it carries the risk of contrast-induced nephro-
toxicity, radiation exposure and increased costs. Moreover,
the definition of flow direction of endoleaks and feeding
arteries by CTA is difficult. Stavroupoulos et al.25 found that
conventional angiography was much more sensitive than
CTA. There is no general consensus on the CTA protocol for
endoleak detection, and some authors advocate the
importance of arterial phase26 or delayed phase.27 We use
a triple-phase protocol with a low-dose unenhanced phase,
normal dose arterial and delayed phase, and this method
showed a high specificity and sensitivity.
MRA has been evaluated in the follow-up of EVAR
patients due to the absence of radiation exposure and
a lower risk of nephrotoxicity. However, it is considered
time consuming, costly and not universally available.28 A
few studies suggested that MRA may be more sensitive than
CTA for the detection of endoleaks.10e12 However, these
studies used single-detector and multidetector CT (MDCT)
and standard gadolinium chelates for MRA for endoleak
detection. Gadolinium-BOPTA (gadobenate dimeglumine,Multi- Hance, Bracco, Italy) has a weak protein interac-
tion, leading to an almost two-fold increase in relaxivity
compared with conventional Gd chelates.29 This property
might be useful for the detection of low-flow endoleaks,
where inadequate opacification with contrast medium
represents a major limitation. Recently, Alerci et al.13
reported the results of a prospective, intraindividual
comparison between contrast-enhanced MRA, with a high-
relaxivity MR contrast medium and 16-slice multidetector
CTA. They showed superior sensitivity of MRA for the
detection of endoleaks compared with CTA. However, this
finding did not translate into therapeutic consequences for
the patients, as none of the endoleaks undetected on CTA
were associated with an increase of aneurysm size. A
potential drawback is that stainless steel stents are ferro-
magnetic and, therefore, at risk of migration by the strong
magnetic field.30 Furthermore, they cause extensive arte-
facts. For example, the elgiloy stents (an alloy of cobalt,
chromium and nickel), may obscure the stent lumen.
Therefore, only patients with MR-compatible nitinol stent
grafts should be considered for MRA surveillance. Endoleak
detection in patients with MR imaging-compatible stents is
relatively more sensitive as showed in previous
studies11,13,31 as confirmed by the findings of our study.
In the present study, CEUS was significantly more
sensitive and specific than CDUS in the identification of
leaks (p < 0.001), somewhat more accurate than CTA and of
similar accuracy to MRA. CEUS allowed better classification
of endoleaks in 10, two and one cases compared with CDUS,
CTA and MRA, respectively. It is noteworthy that four cases
of missed endoleak at CTA or endotensive endoleak were
probably due to metallic artefact in two cases, and in the
remaining two cases because of the small extent of endo-
leak. CEUS detected these two endoleak late after 80 s.
Regarding the classification of endoleaks, CEUS classified
in two cases that were misdiagnosed by CTA and MRA as
type III endoleak by the clear evidence of inflow vessels
such as hypertrophic lumbar arteries. Moreover, CEUS has
the advantage over CTA to provide haemodynamic infor-
mation on blood flow and direction, in addition to the
morphological evaluation, with the possibility of comparing
in real time, on the same screen, the baseline and con-
trastographic images.
CEUS was performed with one bolus of 2.4 ml of second-
generation contrast agent followed by 5 ml of saline in
agreement with Iezzi et al.,9 who showed that 2.4 ml should
be preferred to 1.2 ml because it provides significantly
better results in intensity and duration of contrast
enhancement and, consequently, in visualisation. The need
US, CEUS, CTA and MRA after EVAR 191for a second bolus should be limited to better characterise
endoleak in difficult cases. Furthermore, US contrast media
in this as well as in previous studies proved to be safe.
Contrary to the findings reported by Iezzi et al.,9 in our
study, all patients treated with ‘low permeability’ design
Gore Excluder endoprostheses were studied with sono-
graphic imaging (CDUS as well as CEUS) at 1 month after
EVAR, although the only case in whom CEUS failed to detect
the endoleak was one treated with this type of device.
Despite the large number of patients participating in this
study, we have observed a small number of endoleaks. This
might have led to a potential bias on the evaluation of the
diagnostic accuracy of the present methods. Furthermore,
we encountered only type II and III endoleaks, which are
the most frequent types of endoleaks. Therefore, not all
types of endoleaks were represented in this investigation.
We suggest that future studies with a larger number of
subjects should be performed to confirm the role of these
imaging modalities, particularly the CEUS, in the follow-up
of EVAR patients.
In conclusion, CDUS is inadequate for the surveillance of
patients after EVAR. The results of the present study
showed that CEUS is an effective tool for surveillance after
EVAR as it is fast, cheaper but equally accurate compared
with CTA or MRA, and can be repeated frequently even at
bedside, also in the immediate postoperative period. The
limitations of CEUS are mainly due to its operator depen-
dence and patients’ habitus. Based on these findings, we do
believe that CEUS is a valuable adjunctive imaging modality
to CTA and MRA in detecting endoleaks after EVAR.Acknowledgements
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